Prelude Therapeutics Inc (PRLD) support and resistance · rev $6.5M
Prelude Therapeutics Inc (PRLD) is a biotechnology company listed on NASDAQ.
This page maps Prelude Therapeutics Inc (PRLD) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported PRLD revenue for 2025-09-30 was $6.5M. Net income was -$83.0M. Revenue was up 116.7% from 2024-09-30 to 2025-09-30. PRLD currently screens at market cap $346.5M.
PRLD currently screens at market cap $346.5M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new PRLD 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the PRLD quote page for the session range and the stock page for the full model.
Not investment advice.